Sage files for an approval for its ‘breakthrough’ therapy for postpartum depression
Sage Therapeutics $SAGE is rolling the dice on their “breakthrough” drug for postpartum depression.
The Cambridge, MA-based biotech has filed for an FDA approval …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
